These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21104094)

  • 1. Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis.
    Mignarri A; Rossi S; Ballerini M; Gallus GN; Del Puppo M; Galluzzi P; Federico A; Dotti MT
    J Neurol; 2011 May; 258(5):783-90. PubMed ID: 21104094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with chenodeoxycholic acid in cerebrotendinous xanthomatosis: clinical, neurophysiological, and quantitative brain structural outcomes.
    Amador MDM; Masingue M; Debs R; Lamari F; Perlbarg V; Roze E; Degos B; Mochel F
    J Inherit Metab Dis; 2018 Sep; 41(5):799-807. PubMed ID: 29560583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment.
    Martini G; Mignarri A; Ruvio M; Valenti R; Franci B; Del Puppo M; Federico A; Nuti R; Dotti MT
    Calcif Tissue Int; 2013 Mar; 92(3):282-6. PubMed ID: 23212544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain diffusion tensor imaging changes in cerebrotendinous xanthomatosis reversed with treatment.
    Catarino CB; Vollmar C; Küpper C; Seelos K; Gallenmüller C; Bartkiewicz J; Biskup S; Hörtnagel K; Klopstock T
    J Neurol; 2018 Feb; 265(2):388-393. PubMed ID: 29260356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with Lately Diagnosed Cerebrotendinous Xanthomatosis.
    Yunisova G; Tufekcioglu Z; Dogu O; Bilgic B; Kaleagasi H; Akca Kalem S; Lohmann E; Gurvit HI; Emre M; Hanagasi HA
    Neurodegener Dis; 2019; 19(5-6):218-224. PubMed ID: 32349000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with cerebrotendinous xanthomatosis diagnosed with diverse multisystem involvement.
    Kısa PT; Yildirim GK; Hismi BO; Dorum S; Kusbeci OY; Topak A; Baydan F; Celik FND; Gorukmez O; Gulten ZA; Ekici A; Ozkan S; Yaman A; Arslan N
    Metab Brain Dis; 2021 Aug; 36(6):1201-1211. PubMed ID: 33704661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies.
    Verrips A; Dotti MT; Mignarri A; Stelten BML; Verma S; Federico A
    Neurol Sci; 2020 Apr; 41(4):943-949. PubMed ID: 31863326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrotendinous Xanthomatosis ataxia responsive to CDCA and Riluzole.
    Weissfeld T; Ratliff J
    J Clin Neurosci; 2018 Jul; 53():263-264. PubMed ID: 29731275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing clinical features between Japanese siblings with cerebrotendinous xanthomatosis with a novel compound heterozygous CYP27A1 mutation: a case report.
    Koyama S; Okabe Y; Suzuki Y; Igari R; Sato H; Iseki C; Tanji K; Suzuki K; Ohta Y
    BMC Neurol; 2022 May; 22(1):193. PubMed ID: 35614401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).
    Salen G; Steiner RD
    J Inherit Metab Dis; 2017 Nov; 40(6):771-781. PubMed ID: 28980151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis.
    Verrips A; Wevers RA; Van Engelen BG; Keyser A; Wolthers BG; Barkhof F; Stalenhoef A; De Graaf R; Janssen-Zijlstra F; Van Spreeken A; Gabreëls FJ
    Metabolism; 1999 Feb; 48(2):233-8. PubMed ID: 10024088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnosed cerebrotendinous xanthomatosis patients: clinical, neuroradiological characteristics and therapy results of a single center from Turkey.
    Zubarioglu T; Kiykim E; Yesil G; Demircioglu D; Cansever MS; Yalcinkaya C; Aktuglu-Zeybek C
    Acta Neurol Belg; 2019 Sep; 119(3):343-350. PubMed ID: 29058268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment.
    Huidekoper HH; Vaz FM; Verrips A; Bosch AM
    Eur J Pediatr; 2016 Jan; 175(1):143-6. PubMed ID: 26156051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease.
    Keren Z; Falik-Zaccai TC
    Pediatr Endocrinol Rev; 2009 Sep; 7(1):6-11. PubMed ID: 19696711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrotendinous xanthomatosis associated with immune thrombocytopenia.
    El Husseiny NM
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease.
    Rosafio F; Cavallieri F; Guaraldi P; Taroni F; Nichelli PF; Mandrioli J
    Clin Neurol Neurosurg; 2016 Apr; 143():1-3. PubMed ID: 26874936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chenodeoxycholic Acid: An Update on Its Therapeutic Applications.
    Fiorucci S; Distrutti E
    Handb Exp Pharmacol; 2019; 256():265-282. PubMed ID: 31267167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
    Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
    J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chenodeoxycholic acid (CDCA) treatment during pregnancy in women with cerebrotendinous xanthomatosis (CTX): Lessons learned from 19 pregnancies.
    Zaccai TCF; Hassin-Baer S; Kfir NC; Duell PB; Neerhof M; Sloma R; Roitman M; Kisanuki YY; Verrips A; DeBarber AE
    Genet Med; 2024 May; 26(5):101086. PubMed ID: 38288684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosis.
    Stelten BML; Bonnot O; Huidekoper HH; van Spronsen FJ; van Hasselt PM; Kluijtmans LAJ; Wevers RA; Verrips A
    J Inherit Metab Dis; 2018 Jul; 41(4):641-646. PubMed ID: 28894950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.